EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Delayed‐Onset Cefepime Neurotoxicity in a Patient With Epilepsy and ESRD

Oluwadamilola Omojola iD, Sara Siddiqui, Veronica Zheng iD, Shannon Mccabe, Niti Girish Patel iD, Toluwalase Awoyemi, David Liebovitz

Case Reports in Medicine · 2026-01 · 2026 (1)

DOI: 10.1155/carm/5491008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Case Reports in Medicine, online erschienen am 03.07.2026. Verfasst von Oluwadamilola Omojola und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA, northwestern.edu. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cefepime is associated with central nervous system toxicity, particularly in patients with renal impairment. Cefepime‐induced neurotoxicity (CIN) can manifest as seizures, encephalopathy, and other neurologic disturbances, often mimicking other conditions in complex patients. In this case report, we report a 42‐year‐old woman with end‐stage renal disease on hemodialysis, systemic lupus erythematosus, and epilepsy who presented with recurrent seizures after four months of indefinite cefepime therapy for chronic Pseudomonas aeruginosa catheter‐related bacteremia. Despite therapeutic clobazam levels and stable metabolic parameters, she experienced multiple seizure episodes during a dialysis session. Further investigation revealed characteristic electroencephalography (EEG) for cefepime neurotoxicity as well as elevated serum cefepime level. Following immediate cefepime discontinuation and transition to ceftazidime with optimization of antiepileptic therapy, the patient remained seizure‐free for the remainder of hospitalization. This case highlights the diagnostic challenge of cefepime neurotoxicity in patients with multiple comorbidities, particularly those with baseline seizure disorders and renal dysfunction. Clinicians should maintain a high suspicion for CIN in patients with renal impairment presenting with new or worsening seizures, utilize EEG findings and therapeutic drug monitoring when available, and promptly discontinue cefepime when toxicity is suspected.

Schlagwörter

Stichwörter der Autor:innen

cefepimedrug-induced encephalopathyelectroencephalographyend-stage renal diseasehemodialysisneurotoxicityseizures

Autor:innen und Institutionen

  • Department of Internal Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA, northwestern.edu.
  • Department of Internal Medicine, McGaw Medical Center, Northwestern University, Chicago, Illinois, USA, northwestern.edu.

ORCID-Profile: Oluwadamilola Omojola, Veronica Zheng, Niti Girish Patel

Zitieren

APA

Omojola, O., Siddiqui, S., Zheng, V., Mccabe, S., Patel, N. G., Awoyemi, T., & Liebovitz, D. (2026). Delayed‐Onset Cefepime Neurotoxicity in a Patient With Epilepsy and ESRD. Case Reports in Medicine, 2026(1). https://doi.org/10.1155/carm/5491008

Vancouver

Omojola O, Siddiqui S, Zheng V, Mccabe S, Patel NG, Awoyemi T, et al. Delayed‐Onset Cefepime Neurotoxicity in a Patient With Epilepsy and ESRD. Case Reports in Medicine. 2026;2026(1). doi:10.1155/carm/5491008

BibTeX
@article{Omojola2026,
  author = {Omojola, Oluwadamilola and Siddiqui, Sara and Zheng, Veronica and Mccabe, Shannon and Patel, Niti Girish and Awoyemi, Toluwalase and Liebovitz, David},
  title = {Delayed‐Onset Cefepime Neurotoxicity in a Patient With Epilepsy and ESRD},
  journal = {Case Reports in Medicine},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/carm/5491008}
}
Kostenlos starten →